Atlas Bio raised €11M in a Seed round in Oct 2026. The company is based in Basel, Switzerland. Investors in the round: Creandum, First Momentum Ventures, Lea Partners. Data as of 27 Oct 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
